Date published: 2026-5-26

1-800-457-3801

SCBT Portrait Logo
Seach Input

HHV-6 gp90 Antibody (2003): sc-58157

2.0(1)
Write a reviewAsk a question

Datasheets
  • HHV-6 gp90 Antibody (2003) is a mouse monoclonal IgG2 provided at 100 µg/ml
  • raised against HHV-6 herpesvirus type 6
  • recommended for detection of a 90 KDa glycoprotein of HHV-6 origin by WB, IP and IHC (P); not recommended for IF
  • At present, we have not yet completed the identification of the preferred secondary detection reagent(s) for HHV-6 gp90 Antibody (2003). This work is in progress.
    Gene Editing Promo Banner

    QUICK LINKS

    SEE ALSO...

    HHV-6 gp90 Antibody (2003) is a mouse monoclonal IgG2 antibody that detects HHV-6 gp90 protein by western blotting (WB), immunoprecipitation (IP), and immunohistochemistry with paraffin-embedded sections (IHCP). Anti-HHV-6 gp90 antibody (2003) is available in a non-conjugated form, providing researchers with a versatile tool for studying this important glycoprotein, which is approximately 90 kDa in size. HHV-6 gp90 protein plays a crucial role in the viral life cycle, functioning as a glycoprotein that facilitates viral entry into host cells by interacting with cellular receptors. This interaction enables HHV-6 to establish infection and persist within the host, as HHV-6 can remain latent in various tissues, including monocytes, macrophages, and salivary glands. Understanding HHV-6 gp90′s function is essential for elucidating the pathogenesis of diseases associated with HHV-6, such as febrile illnesses and potential links to demyelinating conditions like multiple sclerosis. The presence of HHV-6 DNA in serum samples of patients with these conditions underscores the importance of studying HHV-6 gp90, as research may provide insights into the virus′s role in disease progression and the development of targeted therapeutic strategies.

    For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

    Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA

    LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences

    HHV-6 gp90 Antibody (2003) References:

    1. The HHV6 paradox: ubiquitous commensal or insidious pathogen? A two-step in situ PCR approach.  |  Blumberg, BM., et al. 2000. J Clin Virol. 16: 159-78. PMID: 10738136
    2. Human herpesvirus 6 (HHV6) infection.  |  Abdel-Haq, NM. and Asmar, BI. 2004. Indian J Pediatr. 71: 89-96. PMID: 14979393
    3. Human herpesvirus 6 (HHV6) DNA persistence and reactivation in healthy children.  |  Caserta, MT., et al. 2004. J Pediatr. 145: 478-84. PMID: 15480370
    4. Lack of association of polyomavirus and herpesvirus types 6 and 7 in human lymphomas.  |  Hernández-Losa, J., et al. 2005. Cancer. 103: 293-8. PMID: 15593086
    5. Fatal pulmonary failure attributable to viral pneumonia with human herpes virus 6 (HHV6) in a young immunocompetent woman.  |  Merk, J., et al. 2005. J Intensive Care Med. 20: 302-6. PMID: 16206417
    6. [Drug hypersensitivity syndrome associated with a primary HHV6 infection].  |  Debarbieux, S., et al. 2006. Ann Dermatol Venereol. 133: 145-7. PMID: 16508598
    7. Human herpesvirus 6 (HHV6) and chronic fatigue syndrome (CFS).  |  Ablashi, DV., et al. 1991. Can Dis Wkly Rep. 17 Suppl 1E: 33-40. PMID: 1669351
    8. Three new human herpesviruses (HHV6, 7, and 8).  |  Levy, JA. 1997. Lancet. 349: 558-63. PMID: 9048803
    9. The latency rate of human herpesvirus 6 (HHV6) in positive and negative human immunodeficiency virus (HIV) infection of intravenous drug users (IVDU).  |  Jayavasu, C., et al. 1997. Asian Pac J Allergy Immunol. 15: 29-33. PMID: 9251845

    Ordering Information

    Product NameCatalog #UNITPriceQtyFAVORITES

    HHV-6 gp90 Antibody (2003)

    sc-58157
    100 µg/ml
    $322.00